BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2357680)

  • 1. Cytogenetic analysis of malignant mesothelioma.
    Hagemeijer A; Versnel MA; Van Drunen E; Moret M; Bouts MJ; van der Kwast TH; Hoogsteden HC
    Cancer Genet Cytogenet; 1990 Jul; 47(1):1-28. PubMed ID: 2357680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma.
    Tiainen M; Tammilehto L; Rautonen J; Tuomi T; Mattson K; Knuutila S
    Br J Cancer; 1989 Oct; 60(4):618-26. PubMed ID: 2803935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom chromosomal abnormalities in malignant pleural mesothelioma.
    Tiainen M; Tammilehto L; Mattson K; Knuutila S
    Cancer Genet Cytogenet; 1988 Jul; 33(2):251-74. PubMed ID: 3164248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients.
    Tammilehto L; Tuomi T; Tiainen M; Rautonen J; Knuutila S; Pyrhönen S; Mattson K
    Eur J Cancer; 1992; 28A(8-9):1373-9. PubMed ID: 1325175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of asbestos-induced chromosomal aberrations in short-term cultured human mesothelial cells.
    Olofsson K; Mark J
    Cancer Genet Cytogenet; 1989 Aug; 41(1):33-9. PubMed ID: 2766251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent chromosome 6 abnormalities in malignant mesothelioma.
    Ribotta M; Roseo F; Salvio M; Castagneto B; Carbone M; Procopio A; Giordano A; Mutti L
    Monaldi Arch Chest Dis; 1998 Apr; 53(2):228-35. PubMed ID: 9689813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. del(6q) as a possible primary change in malignant mesothelioma.
    Meloni AM; Stephenson CF; Li FP; Sandberg AA
    Cancer Genet Cytogenet; 1992 Mar; 59(1):57-61. PubMed ID: 1555192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomic hybridisation in malignant deciduoid mesothelioma.
    Scattone A; Pennella A; Gentile M; Musti M; Nazzaro P; Buonadonna AL; Marzullo A; Cavone D; Pollice L; Serio G
    J Clin Pathol; 2006 Jul; 59(7):764-9. PubMed ID: 16569690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal deletion in patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Sugarbaker DJ
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):42-4. PubMed ID: 19346221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic findings in an effusion secondary from pleural mesothelioma.
    Bello MJ; Rey JA; Avilés MJ; Arevalo M; Benítez J
    Cancer Genet Cytogenet; 1987 Nov; 29(1):75-9. PubMed ID: 3478131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.
    Pelin-Enlund K; Husgafvel-Pursiainen K; Tammilehto L; Klockars M; Jantunen K; Gerwin BI; Harris CC; Tuomi T; Vanhala E; Mattson K
    Carcinogenesis; 1990 Apr; 11(4):673-81. PubMed ID: 2323006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monosomy 14, monosomy 22 and 13q--three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques.
    Mark J
    Acta Cytol; 1978; 22(5):398-401. PubMed ID: 281850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clonal chromosome abnormalities in a case of pleural mesothelioma].
    Pegoraro M; Bersi M; Gasparini C; Cardini G; Ruffoni A
    Arch Sci Med (Torino); 1973; 130(2):125-30. PubMed ID: 17342920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal alterations in early stages of malignant mesotheliomas.
    Simon F; Johnen G; Krismann M; Müller KM
    Virchows Arch; 2005 Oct; 447(4):762-7. PubMed ID: 16012846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant mesothelioma: attributable risk of asbestos exposure.
    Spirtas R; Heineman EF; Bernstein L; Beebe GW; Keehn RJ; Stark A; Harlow BL; Benichou J
    Occup Environ Med; 1994 Dec; 51(12):804-11. PubMed ID: 7849863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: possible sites of tumor suppressor genes.
    Flejter WL; Li FP; Antman KH; Testa JR
    Genes Chromosomes Cancer; 1989 Nov; 1(2):148-54. PubMed ID: 2487155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyotypic changes in the preclinical and subsequent stages of malignant mesothelioma: a case report.
    Hansteen IL; Hilt B; Lien JT; Skaug V; Haugen A
    Cancer Genet Cytogenet; 1993 Oct; 70(2):94-8. PubMed ID: 7694791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of chromosomes 7 and 22 in human malignant pleural mesothelioma: correlation between Southern blot and cytogenetic analyses.
    Tiainen M; Kere J; Tammilehto L; Mattson K; Knuutila S
    Genes Chromosomes Cancer; 1992 Mar; 4(2):176-82. PubMed ID: 1373319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome number correlates with survival in patients with malignant pleural mesothelioma.
    Tiainen M; Rautonen J; Pyrhönen S; Tammilehto L; Mattson K; Knuutila S
    Cancer Genet Cytogenet; 1992 Aug; 62(1):21-4. PubMed ID: 1521229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further analyses of the evolutionary characteristics of a sequentially studied human malignant mesothelioma.
    Mark J; Olofsson K; Månsson T; Stenman G
    Hereditas; 1989; 110(1):85-6. PubMed ID: 2777632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.